JPS50111080A - - Google Patents

Info

Publication number
JPS50111080A
JPS50111080A JP1777474A JP1777474A JPS50111080A JP S50111080 A JPS50111080 A JP S50111080A JP 1777474 A JP1777474 A JP 1777474A JP 1777474 A JP1777474 A JP 1777474A JP S50111080 A JPS50111080 A JP S50111080A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1777474A
Other languages
Japanese (ja)
Other versions
JPS587626B2 (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JP49017774A priority Critical patent/JPS587626B2/ja
Publication of JPS50111080A publication Critical patent/JPS50111080A/ja
Publication of JPS587626B2 publication Critical patent/JPS587626B2/ja
Expired legal-status Critical Current

Links

Landscapes

  • Quinoline Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
JP49017774A 1974-02-13 1974-02-13 ナフチリジン オヨビ キノリンユウドウタイノセイホウ Expired JPS587626B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP49017774A JPS587626B2 (ja) 1974-02-13 1974-02-13 ナフチリジン オヨビ キノリンユウドウタイノセイホウ

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP49017774A JPS587626B2 (ja) 1974-02-13 1974-02-13 ナフチリジン オヨビ キノリンユウドウタイノセイホウ

Publications (2)

Publication Number Publication Date
JPS50111080A true JPS50111080A (cs) 1975-09-01
JPS587626B2 JPS587626B2 (ja) 1983-02-10

Family

ID=11953047

Family Applications (1)

Application Number Title Priority Date Filing Date
JP49017774A Expired JPS587626B2 (ja) 1974-02-13 1974-02-13 ナフチリジン オヨビ キノリンユウドウタイノセイホウ

Country Status (1)

Country Link
JP (1) JPS587626B2 (cs)

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54132582A (en) * 1978-02-24 1979-10-15 Bayer Ag Manufacture of 44pyridonee33carboxylic acid and*or its derivative
JPS5547658A (en) * 1978-09-29 1980-04-04 Kyorin Pharmaceut Co Ltd Substituted quinolinecarboxylic acid derivative
JPS55100364A (en) * 1979-01-26 1980-07-31 Dainippon Pharmaceut Co Ltd Pyridonecarboxylic acid derivative and its salt
JPS5772981A (en) * 1980-10-22 1982-05-07 Dainippon Pharmaceut Co Ltd 1,8-naphthyridine derivative and its salt
JPS5777683A (en) * 1980-09-03 1982-05-15 Bayer Ag 7-amino-1-cyclopropyl-4-oxo-1,4-dihydro- naphthyridine-3-carboxylic acids or salts thereof, manufacture and antibacterial thereof as active ingredient
US4341784A (en) * 1979-09-28 1982-07-27 Dainippon Pharmaceutical Co., Ltd. Naphthyridine derivatives
EP0726270A1 (de) 1995-02-09 1996-08-14 Bayer Ag 1,6-Naphthyridoncarbonsäurederivate
WO2011031745A1 (en) 2009-09-09 2011-03-17 Achaogen, Inc. Antibacterial fluoroquinolone analogs
US8940752B2 (en) 2009-06-29 2015-01-27 Incyte Corporation Pyrimidinones as PI3K inhibitors
US9062055B2 (en) 2010-06-21 2015-06-23 Incyte Corporation Fused pyrrole derivatives as PI3K inhibitors
US9707233B2 (en) 2011-09-02 2017-07-18 Incyte Holdings Corporation Heterocyclylamines as PI3K inhibitors
US9732097B2 (en) 2015-05-11 2017-08-15 Incyte Corporation Process for the synthesis of a phosphoinositide 3-kinase inhibitor
US9815839B2 (en) 2010-12-20 2017-11-14 Incyte Corporation N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitors
US9944646B2 (en) 2012-04-02 2018-04-17 Incyte Holdings Corporation Bicyclic azaheterocyclobenzylamines as PI3K inhibitors
US9988401B2 (en) 2015-05-11 2018-06-05 Incyte Corporation Crystalline forms of a PI3K inhibitor
US10077277B2 (en) 2014-06-11 2018-09-18 Incyte Corporation Bicyclic heteroarylaminoalkyl phenyl derivatives as PI3K inhibitors
US10336759B2 (en) 2015-02-27 2019-07-02 Incyte Corporation Salts and processes of preparing a PI3K inhibitor
US12226418B2 (en) 2018-06-01 2025-02-18 Incyte Corporation Dosing regimen for the treatment of PI3K related disorders

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4826772A (cs) * 1971-08-11 1973-04-09

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4826772A (cs) * 1971-08-11 1973-04-09

Cited By (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54132582A (en) * 1978-02-24 1979-10-15 Bayer Ag Manufacture of 44pyridonee33carboxylic acid and*or its derivative
JPH01246265A (ja) * 1978-02-24 1989-10-02 Bayer Ag ４‐ピリドン‐３‐カルボン酸誘導体
JPS5547658A (en) * 1978-09-29 1980-04-04 Kyorin Pharmaceut Co Ltd Substituted quinolinecarboxylic acid derivative
JPS55100364A (en) * 1979-01-26 1980-07-31 Dainippon Pharmaceut Co Ltd Pyridonecarboxylic acid derivative and its salt
US4341784A (en) * 1979-09-28 1982-07-27 Dainippon Pharmaceutical Co., Ltd. Naphthyridine derivatives
JPS5777683A (en) * 1980-09-03 1982-05-15 Bayer Ag 7-amino-1-cyclopropyl-4-oxo-1,4-dihydro- naphthyridine-3-carboxylic acids or salts thereof, manufacture and antibacterial thereof as active ingredient
JPS5772981A (en) * 1980-10-22 1982-05-07 Dainippon Pharmaceut Co Ltd 1,8-naphthyridine derivative and its salt
EP0726270A1 (de) 1995-02-09 1996-08-14 Bayer Ag 1,6-Naphthyridoncarbonsäurederivate
US10829502B2 (en) 2009-06-29 2020-11-10 Incyte Corporation Pyrimidinones as PI3K inhibitors
US11401280B2 (en) 2009-06-29 2022-08-02 Incyte Holdings Corporation Pyrimidinones as PI3K inhibitors
US8940752B2 (en) 2009-06-29 2015-01-27 Incyte Corporation Pyrimidinones as PI3K inhibitors
US10428087B2 (en) 2009-06-29 2019-10-01 Incyte Corporation Pyrimidinones as PI3K inhibitors
US9975907B2 (en) 2009-06-29 2018-05-22 Incyte Holdings Corporation Pyrimidinones as PI3K inhibitors
WO2011031745A1 (en) 2009-09-09 2011-03-17 Achaogen, Inc. Antibacterial fluoroquinolone analogs
US9062055B2 (en) 2010-06-21 2015-06-23 Incyte Corporation Fused pyrrole derivatives as PI3K inhibitors
US9815839B2 (en) 2010-12-20 2017-11-14 Incyte Corporation N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitors
US11433071B2 (en) 2011-09-02 2022-09-06 Incyte Corporation Heterocyclylamines as PI3K inhibitors
US10376513B2 (en) 2011-09-02 2019-08-13 Incyte Holdings Corporation Heterocyclylamines as PI3K inhibitors
US9730939B2 (en) 2011-09-02 2017-08-15 Incyte Holdings Corporation Heterocyclylamines as PI3K inhibitors
US10092570B2 (en) 2011-09-02 2018-10-09 Incyte Holdings Corporation Heterocyclylamines as PI3K inhibitors
US12201636B2 (en) 2011-09-02 2025-01-21 Incyte Corporation Heterocyclylamines as PI3K inhibitors
US11819505B2 (en) 2011-09-02 2023-11-21 Incyte Corporation Heterocyclylamines as PI3K inhibitors
US10646492B2 (en) 2011-09-02 2020-05-12 Incyte Corporation Heterocyclylamines as PI3K inhibitors
US9707233B2 (en) 2011-09-02 2017-07-18 Incyte Holdings Corporation Heterocyclylamines as PI3K inhibitors
US9944646B2 (en) 2012-04-02 2018-04-17 Incyte Holdings Corporation Bicyclic azaheterocyclobenzylamines as PI3K inhibitors
US10259818B2 (en) 2012-04-02 2019-04-16 Incyte Corporation Bicyclic azaheterocyclobenzylamines as PI3K inhibitors
US10479803B2 (en) 2014-06-11 2019-11-19 Incyte Corporation Bicyclic heteroarylaminoalkyl phenyl derivatives as PI3K inhibitors
US11999751B2 (en) 2014-06-11 2024-06-04 Incyte Corporation Bicyclic heteroarylaminoalkyl phenyl derivatives as PI3K inhibitors
US10077277B2 (en) 2014-06-11 2018-09-18 Incyte Corporation Bicyclic heteroarylaminoalkyl phenyl derivatives as PI3K inhibitors
US11130767B2 (en) 2014-06-11 2021-09-28 Incyte Corporation Bicyclic heteroarylaminoalkyl phenyl derivatives as PI3K inhibitors
US10336759B2 (en) 2015-02-27 2019-07-02 Incyte Corporation Salts and processes of preparing a PI3K inhibitor
US11084822B2 (en) 2015-02-27 2021-08-10 Incyte Corporation Salts and processes of preparing a PI3K inhibitor
US12024522B2 (en) 2015-02-27 2024-07-02 Incyte Corporation Salts and processes of preparing a PI3K inhibitor
US9732097B2 (en) 2015-05-11 2017-08-15 Incyte Corporation Process for the synthesis of a phosphoinositide 3-kinase inhibitor
US9988401B2 (en) 2015-05-11 2018-06-05 Incyte Corporation Crystalline forms of a PI3K inhibitor
US10125150B2 (en) 2015-05-11 2018-11-13 Incyte Corporation Crystalline forms of a PI3K inhibitor
US12226418B2 (en) 2018-06-01 2025-02-18 Incyte Corporation Dosing regimen for the treatment of PI3K related disorders

Also Published As

Publication number Publication date
JPS587626B2 (ja) 1983-02-10

Similar Documents

Publication Publication Date Title
AU7459474A (cs)
AU495930B2 (cs)
AU485022B2 (cs)
AR199810A1 (cs)
AU7465674A (cs)
AU480501A (cs)
AU482110A (cs)
AU480049A (cs)
AU480069A (cs)
AU480264A (cs)
AU480308A (cs)
AU480371A (cs)
BG20669A1 (cs)
AU480902A (cs)
AU480925A (cs)
AU481220A (cs)
AU481597A (cs)
CH560148A5 (cs)
BE836685A (cs)
AU481934A (cs)
BE833391A (cs)
AU482307A (cs)
AU479765A (cs)
AU490706A (cs)
AU479523A (cs)